Name: SGMT Balance Sheet - Sagimet Biosciences Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SGMT - Sagimet Biosciences Inc.

USD | NASDAQ | Healthcare

SGMT Balance Sheet - Sagimet Biosciences Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21
Cash And Short Term Investments
Cash And Equivalents	36.6	35.0	32.5	42.3	64.7	75.8	77.0	96.0	176.8	75.1	101.8	18.5	-	0.2	-	-	-
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	67.9	78.1	84.2	83.1	79.9	75.4	75.5	70.4	16.9	19.8	0.0	0.0	-	32.2	-	-	-
Cash And Short Term Investments	104.5	113.1	116.7	125.4	144.6	151.3	152.5	166.4	193.7	94.9	101.8	18.5	-	32.3	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Liabilities
Accounts Payable	2.3	1.3	4.2	1.9	3.2	1.4	1.2	2.0	0.5	0.2	1.7	2.7	-	1.1	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Equity
Common Stock	-	-	-	-	-	-	-	-	-	-	-	0.0	-	0.0	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Cash And Short Term Investments
Cash And Equivalents	35.0	75.8	75.1	0.2	-
Restricted Cash	-	-	-	-	-
Short Term Investments	78.1	75.4	19.8	32.2	-
Cash And Short Term Investments	113.1	151.3	94.9	32.3	-
Receivables
Accounts Receivable	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-
Prepaid Expenses	3.3	1.5	1.7	0.4	-
Other Current Assets	0.2	0.2
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Property,Plant & Equipment Net	-
Current Liabilities
Accounts Payable	1.3	1.4	0.2	1.1	-
Short Term Debt	-	-	-	-	-
Deferred Revenue Current	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-	-	0.1	-
Deferred Revenue Non-Current	-
Common Equity
Common Stock	-	-	-	0.0	-
Additional Paid In Capital	457.6	450.9	340.8	35.0	-
Retained Earnings	(346.3)	(295.3)
Supplementary Data
Total Debt	-	-	-	-	-
Net debt	-	-	-	-	-
Working Capital	111.3	148.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)